Moshe Mittelman - Short Bio

Moshe Mittelman MD, completed his term as the Chairman, Department of Medicine, at the Tel Aviv Sourasky (Ichilov) Medical Center, in 2020. He continues as a senior consultant for Medicine and Hematology. He is also Professor Emeritus, in medicine and hematology, the School of Medicine, Tel Aviv University.  

Among other tasks, Prof. Mittelman serves as the Chief Technology Officer, Scientific-Medical Director and a consultant for a biotech group (TALENT) and investors, and is involved in several biotech start-ups companies; In 2019 he established, and continues to run a hematology-oncology service in the LISOD Oncology Center, in Kiev, Ukraine; He serves as the Chairman, The Scientific Board, the (International) MDS Foundation (From 2021); Since July 2023, Moshe is the Chairman of the Israel Cancer Association.     

Professor Mittelman graduated from the Faculty of Medicine, Tel Aviv University in 1976, and completed a residency in Internal Medicine at the Hasharon Hospital, Petah-Tikva, Israel. He later undertook a Combined Clinical and Research Fellowship Programme in hematology and oncology at the George Washington University Medical Center, Washington DC, USA, and The National Institutes of Health (NIH), Bethesda, USA, before returning to Israel in 1989. On returning to Israel, he served as Deputy-Director (1989-1994) and then Director (1994-2003), Department of Medicine B, Hasharon Hospital. In 2003 he moved to Tel-Aviv Sourasky (Ichilov) Medical Center, to serve as the Chief of Medicine A and the Chairman of The Department of Medicine (9 wards, 360 beds), till 2020.   

Professor Mittelman’s research interests include basic and clinical aspects of stem cell disorders such as myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), multiple myeloma, basic and clinical effects of erythropoietin, translational research of malignant hematology and applying digitalization into practical medicine. He published more than 240 professional papers and 200 abstracts (in international meetings) summarizing his clinical and research activities in prestigious journals such as Blood; Haematologica; British Journal of Haematology; American Journal of Hematology; Lancet Haematology, Annals of Hematology; Leukemia; Leukemia Research; Annals of Internal Medicine; Journal of Clinical Oncology, and others. He was a member of the editorial board of European Journal of Internal Medicine, and currently serves in the editorial board of the Israel Medical Association Journal (IMAJ), Journal of Clinical Medicine (also co-editor) and Haematologica, as well as a reviewer for the top journals in hematology, oncology and medicine.      

Over the years Moshe has served in academic and public duties, including Chairman, the admission committee for medical students, TAU; The National Committee for new technologies in public health ("Vaadat Sal"); BOD, Israel Cancer Association (he is currently the chairman); Board of Trustees, The Academic College Tel Aviv-Jaffa; Secretary & Chairman, Israel Society of Internal Medicine; President, Israel Society of Hematology; The national committee for clinical trials (Helsinki, co-Chair), Israel Ministry of Health; The national council of cancer.